Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
$14.70
+0.1%
$14.64
$6.41
$14.77
$940.21M0.84757,360 shs2.39 million shs
Amphenol Co. stock logo
APH
Amphenol
$88.28
+3.2%
$73.49
$54.77
$88.50
$106.78B1.17.50 million shs7.49 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
0.00%0.00%0.00%0.00%0.00%
Amphenol Co. stock logo
APH
Amphenol
+3.08%+2.34%+16.45%+33.61%+29.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
Amphenol Co. stock logo
APH
Amphenol
3.9051 of 5 stars
2.33.01.72.13.62.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
0.00
N/AN/AN/A
Amphenol Co. stock logo
APH
Amphenol
2.62
Moderate Buy$82.77-6.24% Downside

Current Analyst Ratings Breakdown

Latest ANCR, AMYT, AGY, and APH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2025
Amphenol Co. stock logo
APH
Amphenol
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$85.00 ➝ $100.00
5/1/2025
Amphenol Co. stock logo
APH
Amphenol
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$63.00 ➝ $70.00
4/24/2025
Amphenol Co. stock logo
APH
Amphenol
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$78.00 ➝ $85.00
4/24/2025
Amphenol Co. stock logo
APH
Amphenol
US Capital Advisors
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$85.00
4/24/2025
Amphenol Co. stock logo
APH
Amphenol
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$72.00 ➝ $80.00
4/24/2025
Amphenol Co. stock logo
APH
Amphenol
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$75.00 ➝ $85.00
4/24/2025
Amphenol Co. stock logo
APH
Amphenol
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$85.00 ➝ $91.00
4/24/2025
Amphenol Co. stock logo
APH
Amphenol
Fox Advisors
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$85.00
4/24/2025
Amphenol Co. stock logo
APH
Amphenol
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$73.00 ➝ $85.00
4/17/2025
Amphenol Co. stock logo
APH
Amphenol
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$90.00 ➝ $85.00
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
$222.54M4.22$0.98 per share14.98$5.58 per share2.63
Amphenol Co. stock logo
APH
Amphenol
$16.78B6.36$3.20 per share27.58$8.17 per share10.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
$1M-$0.06N/A735.00N/A-8.19%1.70%0.75%N/A
Amphenol Co. stock logo
APH
Amphenol
$2.42B$2.0646.1033.441.9215.92%25.67%12.48%7/23/2025 (Estimated)

Latest ANCR, AMYT, AGY, and APH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/23/2025Q1 2025
Amphenol Co. stock logo
APH
Amphenol
$0.52$0.63+$0.11$0.58$4.20 billion$4.81 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
N/AN/AN/AN/AN/A
Amphenol Co. stock logo
APH
Amphenol
$0.660.75%+27.62%32.04%N/A

Latest ANCR, AMYT, AGY, and APH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Amphenol Co. stock logo
APH
Amphenol
quarterly$0.16500.86%6/17/20256/17/20257/9/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
0.64
1.57
0.94
Amphenol Co. stock logo
APH
Amphenol
0.66
2.37
1.75

Institutional Ownership

CompanyInstitutional Ownership
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
71.31%
Amphenol Co. stock logo
APH
Amphenol
97.01%

Insider Ownership

CompanyInsider Ownership
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
5.66%
Amphenol Co. stock logo
APH
Amphenol
1.67%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amryt Pharma plc stock logo
AMYT
Amryt Pharma
2,02063.96 million60.34 millionNot Optionable
Amphenol Co. stock logo
APH
Amphenol
91,0001.21 billion1.19 billionOptionable

Recent News About These Companies

Brokerages Set Amphenol Co. (NYSE:APH) Target Price at $81.62

New MarketBeat Followers Over Time

Media Sentiment Over Time

Amryt Pharma stock logo

Amryt Pharma NASDAQ:AMYT

Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.

Amphenol stock logo

Amphenol NYSE:APH

$88.28 +2.73 (+3.19%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$88.54 +0.25 (+0.29%)
As of 05/27/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amphenol Corporation, together with its subsidiaries, primarily designs, manufactures, and markets electrical, electronic, and fiber optic connectors in the United States, China, and internationally. It operates through three segments: Harsh Environment Solutions, Communications Solutions, and Interconnect and Sensor Systems. The company offers connectors and connector systems, including harsh environment data, power, high-speed, fiber optic, and radio frequency interconnect products; busbars and power distribution systems; and other connectors. It also provides value-add products, such as backplane interconnect systems, cable assemblies and harnesses, and cable management products; other products comprising flexible and rigid printed circuit boards, hinges, other mechanical, and production related products. In addition, the company offers consumer device, network infrastructure, and other antennas; coaxial, power, and specialty cables; and sensors and sensor-based products. It sells its products through its sales force, independent representatives, and a network of electronics distributors to original equipment manufacturers, electronic manufacturing services companies, original design manufacturers, and service providers in the automotive, broadband communication, commercial aerospace, industrial, information technology and data communication, military, mobile device, and mobile network markets. Amphenol Corporation was founded in 1932 and is headquartered in Wallingford, Connecticut.